Emerging Biopharma
Flexible solutions. Responsive teams. Data-driven insights.
Article
Prevailing Trends in Emerging Biopharma
Strong innovation, greater independence, increasing promotional pressure
Aug 24, 2022
IQVIA presented the first in a series of virtual learning sessions for emerging biopharmaceutical (EBP) companies on the critical success factors for product commercialization. This article summarizes the first session, which focused on prevailing trends in levels of innovation, go-to-market strategies, and promotional spending.
Related solutions
Industry Segments
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.